Behind these statistics lies a deeper and more troubling social divide: that the greatest burden is carried by those in our most deprived communities and minority groups. For many people, chronic pain and reduced mobility are not just health issues; they’re reflections of where people live, work, and the care they can access.

Despite national campaigns calling for greater prioritisation of MSK health and improved community services, outcomes remain starkly uneven across the country. Research shows that people living in the UK’s 20% most deprived areas are more likely to develop and live with long-term MSK pain than those in the 20% least deprived areas, while ethnic minority groups show disproportionately high prevalence rates. 

These inequalities are compounded by a health system already under strain, and come at a time when care backlogs are at record highs.

As digital health and artificial intelligence reshape clinical decision-making, an important question emerges: how can AI and explainable data models help bridge these health inequalities rather than widen them? The answer to this question depends very much on how technology is developed, trained and deployed, and whether fairness, transparency and accessibility are at its core.

Inequality rooted in deprivation

The sad fact of the matter is that musculoskeletal ill health in the UK is not distributed evenly across different social groups. People living in the most deprived areas are significantly more likely to report long-term MSK conditions or chronic pain, showing that this is a societal issue as well as a clinical one. 

These inequalities also have a strong geographical pattern. Chronic pain – which affects 19.2 to 29 million people in the UK – is more prevalent in the North of England than in the South, and within regions it is highest in the North East, and lowest in the South East. People living in the most deprived areas are noticeably more likely to experience musculoskeletal (MSK) conditions. In England, prevalence rises from 17% in the least deprived areas to 21% in the most deprived, a difference of 4 percentage points. The gap is far wider in Scotland, where rates more than double from 12% (least deprived) to 26% (most deprived), and in Wales, where prevalence increases from 13% (least deprived) to 20% (most deprived).

These regional disparities matter because they mirror wider disparities in employment, housing, access to services, and healthy life expectancy, all of which are contributing factors to the development of MSK problems.

The causal determinants are not purely medical or geographical. Manual and physically demanding work can increase wear and tear on joints and backs, while digital exclusion can make it harder for some patients to navigate online booking systems. Barriers to physiotherapy access also reinforce the problem: if people cannot get early intervention, conditions are more likely to become persistent, potentially leading to long-term disabilities and work-related absences. 

These striking social indicators also extend to women – 36% of UK women have an MSK condition, vs 28% of UK men – and ethnic minority groups. 

Ethnic and gender based disparities

MSK conditions do not affect all communities equally; some are hit disproportionately hard, with ethnic minority groups facing a far higher prevalence of these debilitating conditions. 

Black Caribbean adults, for instance, report MSK prevalence rates of 21.7%, while Pakistani women experience even higher rates at 29.1%, exceeding the national average of 18.4%. These figures highlight how factors like genetics, lifestyle, and healthcare access intersect to amplify risk in specific groups.

Several underlying causes contribute to this disparity. Cultural stigma around pain reporting can delay help-seeking, while diagnostic delays and potential biases in pain assessment – where symptoms from minority patients may be overlooked – can exacerbate the issue. Limitations in culturally sensitive care pathways further entrench the problem, as standard protocols often overlook language barriers, traditional health beliefs, or community-specific risk factors.

This is where AI holds transformative potential. By using pattern recognition across underrepresented data cohorts, explainable models can identify subtle trends, like elevated risks in Pakistani women due to vitamin D deficiency or occupational patterns in Black Caribbean communities, enabling tailored triage and earlier interventions that traditional systems miss. When built transparently, such tools can flag biases upfront, ensuring equitable outcomes rather than perpetuating them through biased black box datasets. 

Backlogs and bottlenecks: The current systemic failures 

The NHS elective care backlog has reached crisis levels, standing at 7.3 million cases as of early 2026, with MSK conditions forming a significant proportion due to surging demand. Trauma and orthopaedics (T&O), the main MSK specialty, has the longest overall waiting list in England, with 808,570 patients waiting – 11% of all waits. But delay in diagnosis and treatment risks turning initially manageable conditions into chronic disabilities, hitting those already affected by social inequality hardest. 

Traditional referral and triage pathways exacerbate the problem. GP-to-specialist waiting times can stretch months, with postcode lotteries determining who gets fast-tracked, often favouring those with better digital access or more affluent patients with assertive advocacy skills. Deprived areas and minority groups that face transport barriers or language issues typically fall further behind, creating a vicious cycle where late intervention locks in poorer health outcomes.

The human and economic toll is immense. Lost productivity from work absences costs billions annually, while quality of life erodes through persistent pain and reduced mobility. In the UK alone, 6.6 million working days were lost in 2022/23 due to work-related MSK disorders, accounting for 21% of all work-related ill health absences.

For the NHS, this inefficiency drains resources on emergency admissions and complex cases that could have been prevented, highlighting the urgent need for smarter, more scalable solutions.

How AI can intervene with an intelligent approach to triage

AI triage systems offer a practical way to cut through NHS backlogs by using natural language processing to analyse patient symptoms from text or voice inputs, generating risk scores that prioritise urgent cases and match them to appropriate pathways like physiotherapy or specialist referral. These tools streamline decision-making, reducing GP workload while speeding up access to care – in some cases enabling self-management or referral within 24 hours – without replacing clinical oversight.

Real-world examples already show promise. Digital MSK platforms like e-triage apps and symptom-checker chatbots deployed in integrated care systems capture detailed patient histories, score severity based on validated algorithms, and direct users to self-management resources or rapid appointments. For instance, Sandwell & West Birmingham NHS Trust used an AI-enabled digital triage system and supported self-management tools to save 1,240 clinical hours over a 12-month evaluation period. These hours were redirected to face-to-face appointments for more urgent cases, contributing to an 8-week reduction in waiting times that allowed the Trust to meet NHS England’s target timelines for elective care. 

Similarly, in NHS Highland, digital triage is saving around £134,000 in GP time and £29,000 in physiotherapy appointments each year, while 75% of assessed patients manage their condition independently through clinically supported self-management programmes, which reduces reliance on clinicians and gives patients greater control and autonomy

For deprived groups, tailored AI-enabled triage could be transformative, especially if models are trained on inclusive (and transparent) datasets that reflect local populations and diverse demographics. By factoring in postcode-linked deprivation scores or ethnicity-specific risk modifiers, these systems can enable faster access for underserved patients, turning inequality data into equitable action.

Explainable AI as an ethical safeguard

Explainable AI moves beyond black-box algorithms by prioritising model transparency, allowing clinicians to trace how decisions are made and spot potential algorithmic biases or decision gaps early. This visibility is crucial in MSK care, where opaque systems could inadvertently prioritise more affluent patients with better symptom articulation over those from deprived backgrounds whose needs might be undervalued.

Interpretable features, like symptom severity weights, deprivation-linked risk adjusters, or ethnicity modifiers, ensure AI outputs align with clinical reasoning, withstand external scrutiny and create a more equitable system. For instance, explainable AI using transparent data models could reveal exactly why a patient from a deprived postcode was fast-tracked for physiotherapy or deferred, making fairness directly auditable, and building trust and accountability into the heart of the system.

AI models trained on unrepresentative datasets will simply replicate pre-existing biases, so inclusive sourcing from diverse MSK patient groups is an ethical necessity to improve access to care. Governance frameworks must embed explainability standards, include ongoing bias audits, and be co-designed with affected communities to foster patient trust and ensure tools serve patients' real needs.

Yet risks persist, particularly digital exclusion, and underserved groups with low digital literacy or poor internet access could be sidelined by app or web-based platforms. Hybrid models, blending digital platforms with face-to-face support, are essential to make these advances truly inclusive.

AI as a catalyst for change in MSK care

AI alone will not erase the inequalities that shape musculoskeletal health, but clinically-led tools can illuminate where they persist and help dismantle them faster. Its potential lies in using intelligent, transparent systems to amplify human insight, reach patients sooner, and uncover patterns that traditional models have long missed. When fairness becomes a design principle rather than a retrospective afterthought, digital tools can shift from amplifying existing disparities to identifying patients in greatest need. 

In this sense, tackling the MSK crisis presents a rare opportunity for transformative change. Artificial intelligence systems using intelligent triage and explainable data models can streamline access, while unlocking clinical hours, so patients get more and better clinical support, not less.

Ultimately, AI should not be seen as a standalone solution but a catalyst for broader structural change that effectively links primary care, digital innovation, and community support that spotlights inequalities without compromising clinical judgement. There is a genuine opportunity to use technology in a way that heals divides, not deepens them.

Ref:

^[1] https://arma.uk.net/wp-content/uploads/2024/03/Musculoskeletal-Health-Inequalities-and-Deprivation-report_v07.pdf

^[2] https://www.arthritis-uk.org/media/flpbvm2m/arthritisuk_state_of_msk_health_-report_2025.pdf

^[3] https://www.arthritis-uk.org/media/flpbvm2m/arthritisuk_state_of_msk_health_-report_2025.pdf 

^[4] https://www.arthritis-uk.org/media/flpbvm2m/arthritisuk_state_of_msk_health_-report_2025.pdf

^[5] https://painkillers.uk/chronic-pain-statistics-uk/

^[6] https://www.arthritis-uk.org/media/flpbvm2m/arthritisuk_state_of_msk_health_-report_2025.pdf

^[7] https://www.arthritis-uk.org/media/flpbvm2m/arthritisuk_state_of_msk_health_-report_2025.pdf

^[8] https://www.arthritis-uk.org/media/flpbvm2m/arthritisuk_state_of_msk_health_-report_2025.pdf

^[9] https://fingertips.phe.org.uk/static-reports/health-trends-in-england/England/musculoskeletal_health.html

^[10] https://www.rcseng.ac.uk/news-and-events/media-centre/press-releases/rtt-jan-2026/

^[11] https://thenhsalliance.org/resources/nhs-activity-tracker-july-2025/acute-sector

^[12] https://www.firstmats.co.uk/blogs/buying-guides/executive-summary-of-hse-work-related-msds-statistics-2023

^[13] https://onlinelibrary.wiley.com/doi/abs/10.1002/msc.70013

^[14]ttps://www.healthtechdigital.com/eleven-nhs-sites-adopt-new-physiotherapy-platform-phio-to-cut-service-wait-times/